The Mullings Group Companies (TMG), a prominent player in the medtech industry, has announced a significant expansion of its operations in Israel as of December 1, 2025. This strategic move is aimed at bolstering TMG’s support for Israel’s dynamic medtech ecosystem and facilitating the connection between Israeli innovations and global markets.
TMG has maintained a presence in Israel for over two decades, collaborating with local companies and assisting Israeli-founded organizations in entering the U.S. market. The establishment of a more robust in-country presence underscores TMG’s commitment to promoting the technological advancements emerging from Israel. This initiative is further enhanced by TMG’s role as a founding member of the U.S./Israel Medtech Delegation, which aims to elevate the visibility of Israeli technology on a global scale.
Leading this initiative is Ido Hadari, a seasoned expert in Israel’s healthcare and medtech sectors. Under his guidance, TMG intends to deepen relationships with both emerging and established companies. This expansion will provide daily support for businesses engaging with current and prospective clients and participating in key industry events.
Joe Mullings, Chairman and CEO of TMG, highlighted the company’s long-standing mission: “For more than two decades, TMG has been committed to building bridges between Israeli companies and the U.S. market. Our goal is to accelerate the speed and scale at which these technologies reach commercial success and patients worldwide.” He emphasized the importance of having a trusted partner like Ido, stating, “TMG’s expanded entrance into Israel marks a powerful moment for the industry.”
Ido Hadari shared insights on the evolving landscape of Israeli medtech, noting, “Israeli medtech and digital health founders have earned their place among the world’s most innovative and driven leaders. When a startup evolves, the stakes rise. Sharp, experienced leadership becomes the difference between breaking through and falling behind.”
The expansion will be officially launched during the annual ICI Meeting, scheduled for December 7-9, 2025. TMG’s participation in this gathering, along with the U.S./Israel Medtech Delegation, highlights its ongoing dedication to fostering collaboration and driving innovation in the medtech field.
Ido’s extensive background enhances TMG’s capabilities in Israel. He has held key positions, including Chief Communications Advisor to the Israeli Minister of Health and Chief Communications & Government Affairs Officer at Maccabi Healthcare Services, one of the largest health providers globally. His experience spans various sectors of the healthcare industry, including venture capital and international consultancy roles.
Founded in 1992, The Mullings Group has successfully completed over 9,000 searches in the medtech, healthtech, and life sciences sectors, establishing itself as a leader in talent acquisition. With offices across the United States, Canada, the United Kingdom, Israel, and the Asia-Pacific region, TMG continues to expand its influence in the medtech and emerging high-tech industries.
As TMG deepens its commitment to Israel’s medtech landscape, the company aims to empower medical device and digital health organizations by providing access to top-tier executives and senior leadership teams. This approach is crucial for companies looking to navigate the complexities of scaling operations in the U.S. market.
With an award-winning media and marketing arm, TMG is positioned as a pivotal player in amplifying the stories of its clients, thereby enhancing their visibility in the competitive landscape of medtech. As the company embarks on this new chapter in Israel, it seeks to continue its legacy of excellence and innovation in the global healthcare arena.
